Venrock Healthcare Capital Partners III, L.P. 13D/13G Filings for Cidara Therapeutics, Inc. (CDTX)

Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Cidara Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-12-04
4:15 pm
Purchase
2024-11-2613GCidara Therapeutics, Inc.
CDTX
Venrock Healthcare Capital Partners III, L.P.1,129,097
9.990%
1,129,097increase
(New Position)
Filing